Essayas Kassahun Kebede

March 10, 2018 11:22 PM ET

Capital Markets

Company Overview of PANTON Capital Group, LLC

Executive Profile

AgeTotal Calculated CompensationThis person is connected to 1 Board Member in 1 organization across 0 different industries.

See Board Relationships
61--

Background

Mr. Kassahun Kebede, also known as Kassy is the Founder, Principal and Managing Partner at PANTON Capital Group. He is a Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee of WorldSpace, Inc. Mr. Kebede earned a M.B.A. from the Wharton School of the University of Pennsylvania in 1991 and a B.S. in electrical engineering from Marquette University in 1985.

Corporate Headquarters

590 Madison Avenue
New York, New York 10022

United States

Phone: 212-582-3100
Fax: 212-582-3134

Board Members Memberships

2005-Present

Director

WorldSpace, Inc.

Education

BS 1985

Marquette University

MBA 1991

University of Pennsylvania - The Wharton School

Other Affiliations

WorldSpace, Inc.

Marquette University

University of Pennsylvania - The Wharton School

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, Den Boer M, WHO Leishmaniasis Control Team Worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671. doi: 10.1371/journal.pone.0035671.[PMC free article][PubMed][Cross Ref]

2. Ngure PK, Kimutai A, Ng’ang’Z W, Rukunga G, Tonui WK. A review of leishmaniasis in Eastern Africa. JNMU. 2009;23:79–86.

3. Anema A, Ritmeijer K. Treating HIV/AIDS and leishmaniasis co-infection in Ethiopia. JAMC. 2005;172:1434–1435.[PMC free article][PubMed]

4. Hailu A, Gebre-Michael T, Berhe N, Balkew M. Leishmaniasis. In: Kloos H, Berhane Y, Hailemariam D, editors. Epidemiology and Ecology of Health and Disease in Ethiopia. 1. Addis Ababa, Ethiopia: Shama Books; 2006. pp. 556–576.

5. Deribe K, Meribo K, Gebre T, Hailu A, Ali A, Aseffa A, Davey G. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasit Vectors. 2012;5:240. doi: 10.1186/1756-3305-5-240.[PMC free article][PubMed][Cross Ref]

6. Tsegaw T, Gadisa E, Seid A, Abera A, Teshome A, Mulugeta A, Herrero M, Argaw D, Jorge A, Aseffa A. Identification of environmental parameters and risk mapping of visceral leishmaniasis in Ethiopia by using geographical information systems and a statistical approach. Geospat Health. 2013;7:299–308.[PubMed]

7. Fuller GK, Lemma A, Haile T, Gemeda N, Kala-azar in Ethiopia survey of south-west Ethiopia. The Leishmanin skin test and epidemiological studies. Ann Trop Med Parasitol. 1979;73:417–430.[PubMed]

8. Ayele T, Ali A. The distribution of visceral leishmaniasis in Ethiopia. Am J Trop Med Hyg. 1984;33:548–552.[PubMed]

9. Alvar J, Bashaye S, Argaw D, Cruz I, Aparicio P, Kassa A, Orfanos G, Parreño F, Babaniyi O, Gudeta N, Cañavate C, Bern C. Kalaazar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment. Am J Trop Med Hyg. 2007;77:275–282.[PubMed]

10. Hailu A, Gramiccia M, Kager PA. Visceral leishmaniasis in Aba-Roba, south-western Ethiopia: prevalence and incidence of active and subclinical infections. Ann Trop Med Parasitol. 2009;103:659–670. doi: 10.1179/000349809X12554106963555.[PubMed][Cross Ref]

11. Bashaye S, Nombela N, Argaw D, Mulugeta A, Herrero M, Nieto J, Chicharro C, Cañavate C, Aparicio P, Vélez ID, Alvar J, Bern C. Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia. Am J Trop Med Hyg. 2009;81:34–39.[PubMed]

12. Tekle A, Neri D, Debessai A. Kalaazar in Humera (north-west Ethiopia) Parassitologia. 1970;72:21–25.

13. Mengesha B, Abuhoy M. Kala-azar among labour migrants in Metema-Humera region of Ethiopia. Trop Geogr Med. 1978;30:199–206.[PubMed]

14. Seblova V, Volfova V, Dvorak V, Pruzinova K, Votyapka J, Kassahun A, Gebre-Michael T, Hailu A, Warburg A, Volf P. Phlebotomusorientalis sandflies from two geographically distant Ethiopian localities: biology, genetic analyses and susceptibility to Leishmaniadonovani. PLoSNegl Trop Dis. 2013;7:e2187. doi: 10.1371/journal.pntd.0002187.[PMC free article][PubMed][Cross Ref]

15. Elnaiem DA, Ward RD, Hassan HK, Miles MA, Frame IA. Infection rates of Leishmaniadonovani in Phlebotomusorientalis from a focus of visceral leishmaniasis in eastern Sudan. Ann Trop Med Parasitol. 1998;92:229–232. doi: 10.1080/00034989860085.[PubMed][Cross Ref]

16. Gebre-Michael T, Balkew M, Berhe N, Hailu A, Mekonnen Y. Further studies on the phlebotominesandflies of the kala-azar endemic lowlands of Humera- Metema (North-West Ethiopia) with observations on their natural blood meal sources. Parasit Vectors. 2010;3:6. doi: 10.1186/1756-3305-3-6.[PMC free article][PubMed][Cross Ref]

17. Elnaiem DA, Connor SJ, Thomson MC, Hassan MM, Hassan HK, Aboud MA, Ashford RW. Environmental determinants of the distribution of Phlebotomusorientalis in Sudan. Ann Trop Med Parasitol. 1998;92:877–887. doi: 10.1080/00034989858925.[PubMed][Cross Ref]

18. Moncaz A, Kirstein O, Gebresellassie A, Lemma W, Yared S, Gebre-Michael T, Hailu A, Shenker M, Warburg A. Characterization of breeding sites of Phlebotomusorientalis-The vector of visceral leishmaniasis in northwestern Ethiopia. Acta Trop. 2014;139C:5–14. doi: 10.1016/j.actatropica.2014.06.013.[PubMed][Cross Ref]

19. Haileselassie B, Ali A. Assessment of insecticide treated nets coverage for malaria control in Kafta-Humera district, Tigray: Possession versus use by high-risk groups. Ethiop. J Health Dev. 2008;22:259–267.

20. Gemetchu T, Zerihune A, Assefa G, Lemma A. Observations on the sandfly (phlebotomidae) fauna of Setit Humera (Northwestern Ethiopia) Ethiop Med J. 1975;13:41–51.[PubMed]

21. ter Horst R, Tefera T, Assefa G, Ebrahim AZ, Davidson RN, Ritmeijer K. Field evaluation of rK39 test and direct agglutination test for diagnosis of visceral leishmaniasis in a population with high prevalence of human immunodeficiency virus in Ethiopia. Am J Trop Med Hyg. 2009;80:929–934.[PubMed]

22. Bern C, Joshi AB, Jha SN, Das ML, Hightower A, Thakur GD, Bista MB. Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective. Am J Trop Med Hyg. 2000;63:184–188.[PubMed]

23. Mukhtar MM, Sharief AH, el Saffi SH, Harith AE, Higazzi TB, Adam AM, Abdalla HS. Detection of antibodies to Leishmaniadonovani in animals in a kala-azar endemic region in eastern Sudan: a preliminary report. Trans R Soc Trop Med Hyg. 2000;94:33–36. doi: 10.1016/S0035-9203(00)90429-2.[PubMed][Cross Ref]

24. Bern C, Hightower WA, Chowdhury R, Ali M, Amann J, Wagatsuma Y, Haque R, Kurkjian K, Vaz EL, Begum M, Akter T, Cetre-Sossah BC, Ahluwalia BI, Secor DE, Breiman FR, Maguire HJ. Risk Factors for Kala-Azar in Bangladesh. Emerg Infect Dis. 2005;11:655–662. doi: 10.3201/eid1105.040718.[PMC free article][PubMed][Cross Ref]

25. Ranjan A, Sur D, Singh VP, Siddique NA, Manna B, Lal CS, Sinha PK, Kishore K, Bhattacharya SK. Risk factors for Indian kala-azar. Am J Trop Med Hyg. 2005;73:74–78.[PubMed]

26. Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmaniadonovani infection and its risk factors. Trop Med Int Health. 2006;11:1792–1799. doi: 10.1111/j.1365-3156.2006.01735.x.[PubMed][Cross Ref]

27. Ryan JR, Mbui J, Rashid JR, Wasunna MK, Kirigi G, Magiri C, Kinoti D, Ngumbi PM, Martin SK, Odera SO, Hochberg LP, Bautista CT, Chan AS. Spatial clustering and epidemiological aspects of visceral leishmaniasis in two endemic villages, Baringo District, Kenya. Am J Trop Med Hyg. 2006;74:308–317.[PubMed]

28. Kolaczinski JH, Reithinger R, Worku DT, Ocheng A, Kasimiro J, Kabatereine N, Brooker S. Risk factors of visceral leishmaniasis in East Africa: a case–control study in Pokot territory of Kenya and Uganda. Int J Epidemiol. 2008;37:344–352. doi: 10.1093/ije/dym275.[PMC free article][PubMed][Cross Ref]

29. Kesari S, Bhunia GS, Kumar V, Jeyaram A, Ranjan A, Das P. Study of house-level risk factors associated in the transmission of Indian Kala-azar. Parasit Vectors. 2010;3:94. doi: 10.1186/1756-3305-3-94.[PMC free article][PubMed][Cross Ref]

30. Khanal B, Picado A, Bhattarai NR, Van Der Auwera G, Das ML, Ostyn B, Davies CR, Boelaert M, Dujardin JC, Rijal S. Spatial analysis of Leishmaniadonovani exposure in humans and domestic animals in a recent kala azar focus in Nepal. Parasitology. 2010;137:1597–1603. doi: 10.1017/S0031182010000521.[PubMed][Cross Ref]

31. Singh SP, Hasker E, Picado A, Gidwani K, Malaviya P, Singh RP, Boelaert M, Sundar S. Risk factors for visceral leishmaniasis in India; Further evidence on the role of domestic animals. Trop Med Int Health. 2010;15:29–35. doi: 10.1111/j.1365-3156.2010.02515.x.[PMC free article][PubMed][Cross Ref]

32. Singh SP, Picado A, Boelaert M, Gidwani K, Andersen EW, Ostyn B, Meheus F, Rai M, Chappuis F, Davies C, Sundar S. The epidemiology of Leishmaniadonovani infection in high transmission foci in India. Trop Med Int Health. 2010;15:12–20. doi: 10.1111/j.1365-3156.2010.02519.x.[PubMed][Cross Ref]

33. Khatun M, Rahim MA, Huda M, Haider N, Ghosh D, Mondal D: Serological Evidence of Visceral Leishmaniasis (VL) among Goats in VL Endemic Areas of Bangladesh, International Society for Infectious Diseases 2012, 15th International congress on Infectious diseases, Bangok, Thailand, June 13–16 2012, Centara Grand &Bangkok Convention Centre at Central World, 15:[Abstract]. ; ᅟ. http://www.xcdsystem.com/icid_ise2012/ISE.279.html.

34. Uranw S, Hasker E, Roy L, Meheus F, Das ML, Bhattarai NR, Rijal S, Boelaert M. An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmaniadonovani. BMC Infect Dis. 2013;13:21. doi: 10.1186/1471-2334-13-21.[PMC free article][PubMed][Cross Ref]

35. Haile T, Anderson SD. Visceral Leishmaniasis in Northern Ethiopia. East Afr Med J. 2006;83:389–392. doi: 10.4314/eamj.v83i7.9451.[PubMed][Cross Ref]

36. Mengistu G, BeleteAyele B. Visceral Leishmaniasis and HIV co-infection in patients admitted to Gondar university hospital, northwest Ethiopia. EthiopJHealth Dev. 2007;21:53–60.

37. Lindtjørn B. Kala-azar in south-west Ethiopia: seasonal variation in disease occurrence. Trans R Soc Trop Med Hyg. 1984;78:790–791. doi: 10.1016/0035-9203(84)90022-1.[PubMed][Cross Ref]

38. Nyunguraa JL, Nyambatib VCS, Muitac M, Eric Muchirid E. Risk factors for the transmission of kala-azar in Fangak, South Sudan. SSMJ. 2011;4:26–29.

39. Medicines Sans Frontiers . Perception of Kalazar among Pokot Communities in Amudat, Uganda. Swizzerland: Final report by Epicenter and MSF; 2002. pp. 348–349.

40. Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, Siddhivinayak H, Kroeger A, Boelaert M. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoSNegl Trop Dis. 2009;3:e355. doi: 10.1371/journal.pntd.0000355.[PMC free article][PubMed][Cross Ref]

41. Alemu A, Esmael N, Dessie Y, Hamdu K, Mathewos B, Birhan W. Knowledge, attitude and practices related to visceral leishmaniasis among residents in Addis Zemen town, South Gondar, Northwest Ethiopia. BMC Public Health. 2013;13:382. doi: 10.1186/1471-2458-13-382.[PMC free article][PubMed][Cross Ref]

42. Bhattarai NR, Van der Auwera G, Rijal S, Picado A, Speybroeck N, Khanal B, De Doncker S, Das ML, Ostyn B, Davies C, Coosemans M, Berkvens D, Boelaert M, Dujardin JC. Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg Infect Dis. 2010;16:231–237. doi: 10.3201/eid1602.090623.[PMC free article][PubMed][Cross Ref]

43.

Categories: 1

0 Replies to “Essayas Kassahun Kebede”

Leave a comment

L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *